Skip to content
The Nexus
BUSINESSJun 26 · 14:20 UTCQUARTZColleen Cabili

Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion

Germany's Merck KGaA is acquiring lab-tools supplier Bio-Techne for $11.3 billion, marking its largest deal since the Sigma-Aldrich buyout. The acquisition expands Merck's presence in proteins, spatial biology, and cell and gene therapy.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Merck KGaAorganizationBio-TechneorganizationSigma-Aldrichorganizationproteinstopicspatial biologytopiccell and gene therapytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting